Immuron (IMRN) Change in Receivables (2016 - 2023)
Immuron (IMRN) recorded quarterly Change in Receivables of $2.2 million in Q4 2023, up 281.59% quarter-over-quarter from $583772.0 in Q4 2022, and up 281.59% on a YoY basis from $583772.0 in Q4 2022.
Immuron (IMRN) Change in Receivables (2016 - 2023) Analysis & Trends
Immuron's Change in Receivables history runs 6 years deep, the most recent figure standing at $2.2 million for Q4 2023.
- In Q4 2023, Change in Receivables rose 281.59% year-over-year to $2.2 million; the TTM figure through Dec 2023 stood at $2.4 million (up 1077.92% YoY), while the FY2025 annual figure was $229194.7, up 589.77% from the prior year.
- Change in Receivables was $2.2 million for Q4 2023 at Immuron, up from $583772.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.2 million in Q4 2023 to a low of -$353939.0 in Q2 2022.
- Historically, Change in Receivables has averaged $486659.0 across 4 years, with a median of $10549.7 in 2020.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables plunged 919.92% in 2022, then jumped 281.59% in 2023.
- A 4-year view of Change in Receivables shows it stood at $10549.7 in 2020, then sank by 428.94% to -$34702.5 in 2021, then jumped by 1782.22% to $583772.0 in 2022, then surged by 281.59% to $2.2 million in 2023.
- The last three Change in Receivables figures came in at $2.2 million (Q4 2023), $583772.0 (Q4 2022), and -$353939.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Immuron | 1.07 Bn | 1.07 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2022 | 583,772.00 |
| Dec 31, 2022 | 583,772.00 |
| Jun 30, 2022 | -353,938.98 |
| Jun 30, 2022 | -353,938.98 |
| Jun 30, 2021 | -34,702.53 |
| Jun 30, 2021 | -34,702.53 |
| Jun 30, 2020 | 10,549.65 |
| Jun 30, 2020 | 10,549.65 |
| Dec 31, 2017 | 923,408.71 |
| Dec 31, 2017 | 923,408.71 |
| Dec 31, 2016 | 501,319.99 |
| Dec 31, 2016 | 501,319.99 |